OpenAlex
PricingAboutJobs
Log inGet started
Work

Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions

HTML

Year: 2016
Type: article
Source: Protein Engineering Design and Selection
DOI: 10.1093/protein/gzw040
Authors: Tilman Schlothauer, Sylvia Herter, Claudia Ferrara Koller, Sandra Grau-Richards, Virginie Steinhart, Christian Spick, Manfred Kubbies, Christian Klein, Pablo Umaña, Ekkehard Mössner
Institutions: Roche Pharma AG (Germany), F. Hoffmann-La Roche AG
Language: English

Topic: Monoclonal and Polyclonal Antibodies Research
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: Fc engineering, IgG1, IgG4, Fc gamma receptor, C1q binding, FcRn binding, anti-drug antibodies, immune effector functions
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2509039973
FWCI: 7.454
Cites: 51
Cited by: 463
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security